# A Study of Metformin to Improve Cardiac Function After LVAD Implantation

> **NCT07666698** · PHASE1,PHASE2 · RECRUITING · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 108 (estimated)

## Conditions studied

- Heart Failure
- Left Ventricular Assist Device

## Interventions

- **DRUG:** Metformin Hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07666698
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2028-07
- **Final completion:** 2029-09
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2026-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07666698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07666698, "A Study of Metformin to Improve Cardiac Function After LVAD Implantation". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07666698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*